Pfizer's Prevenar wins Japanese approval; Judge rules unvaccinated students must stay home during illness;

> Pfizer's ($PFE) Prevenar 13 has scored approval in Japan for use in adults aged 65 and older. Report

> A New York judge has upheld the policy barring unvaccinated students from public schools when another student has a vaccine-preventable disease. Report (sub. req.)

> GlaxoSmithKline's ($GSK) vaccine plant in Texas is about a year away from completion. More

> The GAVI Alliance has approved a new strategic framework to reach an additional 300 million children with vaccines. Release

> Madison Vaccines is expanding its Phase II trial for prostate cancer DNA vaccine MVI-816. Release

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

Suggested Articles

Implementing data integration strategy in your commercialization breaks down traditional healthcare silos and improves patient outcomes.

With COVID vaccinations expected to start in the coming weeks, 2021 is shaping up to be quite a year for the companies with leading vaccines.

The U.K. became the first Western country to authorize a COVID-19 vaccine, making the Pfizer/BioNTech shot the first mRNA vaccine for widespread use.